Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS.

Leukemia · 2014 · PMC4017258 · PMID 24150217

Europe PMC DOI

hedged sentence

0.0650

closest p · 1.3× alpha

0.0650

boldest claim

The sentences

of borderline significanceP =0.065so close (0.05 < p ≤ 0.1)

The association between increasing karyotype complexity and death was of borderline significance (65% increased risk; P =0.065).

also in 1,677 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.